ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.76 USD
-4.03%
Market Closed
Updated:
Apr 19, 2024
ADC Therapeutics SA
Other Equity
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Other Equity Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Other Equity
$-148.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Equity
CHf-51k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Equity
$1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Equity
CHf-10.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Other Equity
CHf48.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Other Equity?
Other Equity
-148.2m
USD
-148.2m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Other Equity amounts to -148.2m USD.
What is ADC Therapeutics SA's Other Equity growth rate?
Other Equity CAGR 1Y
-36 962%
-36 962%
Over the last year, the Other Equity growth was -36 962%.
You don't have any saved screeners yet
